Murphy Pohlad Asset Management LLC Grows Position in Teladoc Health, Inc. $TDOC

Murphy Pohlad Asset Management LLC boosted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 10.5% during the 2nd quarter, Holdings Channel reports. The firm owned 69,600 shares of the health services provider’s stock after acquiring an additional 6,600 shares during the quarter. Murphy Pohlad Asset Management LLC’s holdings in Teladoc Health were worth $606,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of TDOC. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Teladoc Health by 60.8% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider’s stock valued at $316,000 after acquiring an additional 15,030 shares during the last quarter. Golden State Wealth Management LLC boosted its holdings in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 1,690 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Teladoc Health by 18.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 17,377 shares of the health services provider’s stock valued at $138,000 after acquiring an additional 2,652 shares during the last quarter. Farther Finance Advisors LLC boosted its holdings in shares of Teladoc Health by 424.5% in the 2nd quarter. Farther Finance Advisors LLC now owns 9,960 shares of the health services provider’s stock valued at $87,000 after acquiring an additional 8,061 shares during the last quarter. Finally, American Century Companies Inc. boosted its holdings in shares of Teladoc Health by 78.8% in the 1st quarter. American Century Companies Inc. now owns 375,050 shares of the health services provider’s stock valued at $2,985,000 after acquiring an additional 165,332 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Shares of NYSE TDOC opened at $8.75 on Friday. The company’s fifty day moving average price is $8.21 and its 200 day moving average price is $7.70. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The company has a market capitalization of $1.55 billion, a PE ratio of -6.84 and a beta of 1.90. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.49%. The firm had revenue of $626.44 million for the quarter, compared to the consensus estimate of $625.66 million. During the same period in the prior year, the firm posted ($0.19) earnings per share. The firm’s quarterly revenue was down 2.2% compared to the same quarter last year. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. On average, research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Analysts Set New Price Targets

TDOC has been the topic of several recent research reports. Evercore ISI dropped their price objective on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a report on Thursday. Zacks Research raised shares of Teladoc Health from a “hold” rating to a “strong-buy” rating in a report on Friday, October 10th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, October 8th. Citigroup upped their price objective on shares of Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a report on Tuesday, October 21st. Finally, Mizuho initiated coverage on shares of Teladoc Health in a report on Friday, July 25th. They issued a “neutral” rating and a $10.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Teladoc Health has an average rating of “Hold” and an average price target of $9.89.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.